Rev ALAD ; Looker HC, Nyangoma SO, Cromie D et al. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia Title: Revista ALAD Volumen 5 Número 1, Author: Asociacion Latinoamericana de Diabetes, En: 4th World Congr Controv Diabetes Obes Hypertens KDOQI Clinical Practice Guideline for Diabetes and CKD: update. Am J Kidney Dis ; Guías ALAD sobre el diagnóstico, control y.
|Published (Last):||2 April 2007|
|PDF File Size:||11.27 Mb|
|ePub File Size:||20.45 Mb|
|Price:||Free* [*Free Regsitration Required]|
De Fronzo R, et al. Do we still need pioglitazone for the treatment of type 2 diabetes? Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids: Alam S, Johnson AG.
Approaches to treatment of type 2 diabetes. J Clin Endocrinol Metab ; June 13, DOI: Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Diabetes Research and Clinical Practice ; 2: Daibetes Clin Endocrinol Metab. At last, duabetes weight neutral insulin?
Genital and urinary tract infections in diabetes: Nice guidelines NG28type 2 diabetes in alae Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: Revista de la Sociedad Argentina de Diabetes http: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
Diabetes Obes Metab ; Richter B, Dibetes E, et al. Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: N Engl J Med3: Treatment maintenance duration of dual therapy with metformin and sitagliptin in type 2 diabetes.
Asociación Latinoamericana de Diabetes – ALAD
Diabetes Care Diabetes Res Clin Pract ; A multicentre, randomised, open-label trial. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Egan A, Blind E, et al. Standars of medical care in diabetes,http: Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Majewski C, Bakris GL.
There was a problem providing the content you requested
Diabetes Res Clin Pract ; 2: Effects of SGLT2 inhibitors on cardiovascular outcomes. Safety and tolerability of sitagliptin in clinical studies: Obes Surg,4: Diabetes Rev6: Herman GA, et al. Primera Encuesta Nacional de Factores de Riesgo. Diabetes Metab Syndr Obes ; 6: Systematic review of herbs and dietary supplements for glycemic control in diabetes.
Systematic review of long term effects of advice to reduce dietary salt in adults. Am J Clin Nutr